6968 related articles for article (PubMed ID: 3110178)
1. Biological activity, binding, and metabolic fate of Ac-[Nle4, D-Phe7]alpha-MSH4-11NH2 with the F1 variant of B16 melanoma cells.
Panasci LC; McQuillan A; Kaufman M
J Cell Physiol; 1987 Jul; 132(1):97-103. PubMed ID: 3110178
[TBL] [Abstract][Full Text] [Related]
2. Prolonged stimulation of S91 melanoma tyrosinase by [Nle4, D-Phe7]-substituted alpha-melanotropins.
Abdel Malek ZA; Kreutzfeld KL; Marwan MM; Hadley ME; Hruby VJ; Wilkes BC
Cancer Res; 1985 Oct; 45(10):4735-40. PubMed ID: 2992767
[TBL] [Abstract][Full Text] [Related]
3. Enhanced binding and inertness to dehalogenation of alpha-melanotropic peptides labeled using N-succinimidyl 3-iodobenzoate.
Garg PK; Alston KL; Welsh PC; Zalutsky MR
Bioconjug Chem; 1996; 7(2):233-9. PubMed ID: 8983345
[TBL] [Abstract][Full Text] [Related]
4. Potent and prolonged melanotropic activities of the alpha-MSH fragment analog, Ac-[Nle4,D-Phe7]-alpha-MSH4-9-NH2.
Klemes DG; Kreutzfeld KL; Hadley ME; Cody WL; Hruby VJ
Biochem Biophys Res Commun; 1986 Jun; 137(2):722-8. PubMed ID: 3089218
[TBL] [Abstract][Full Text] [Related]
5. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin that "irreversibly" activates melanoma tyrosinase.
Hadley ME; Abdel Malek ZA; Marwan MM; Kreutzfeld KL; Hruby VJ
Endocr Res; 1985; 11(3-4):157-70. PubMed ID: 3009169
[TBL] [Abstract][Full Text] [Related]
6. alpha-Melanocyte-stimulating hormone binding and biological activity in a human melanoma cell line.
Legros F; Coel J; Doyen A; Hanson P; Van Tieghem N; Vercammen-Grandjean A; Fruhling J; Lejeune FJ
Cancer Res; 1981 Apr; 41(4):1539-44. PubMed ID: 6260342
[TBL] [Abstract][Full Text] [Related]
7. A new role for epidermal cell-derived thymocyte activating factor/IL-1 as an antagonist for distinct epidermal cell function.
Swope VB; Abdel-Malek ZA; Sauder DN; Nordlund JJ
J Immunol; 1989 Mar; 142(6):1943-9. PubMed ID: 2466081
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of a variant of B16-mouse melanoma resistant to MSH growth inhibition.
Niles RM; Logue MP
J Supramol Struct; 1979; 11(2):251-8. PubMed ID: 232892
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of S91 melanoma tyrosinase activity by superpotent alpha-melanotropins.
Marwan MM; Abdel Malek ZA; Kreutzfeld KL; Hadley ME; Wilkes BC; Hruby VJ; Castrucci AM
Mol Cell Endocrinol; 1985 Jul; 41(2-3):171-7. PubMed ID: 3926559
[TBL] [Abstract][Full Text] [Related]
10. Binding and internalization of the melanocyte stimulating hormone receptor ligand [Nle4, D-Phe7] alpha-MSH in B16 melanoma cells.
Wong W; Minchin RF
Int J Biochem Cell Biol; 1996 Nov; 28(11):1223-32. PubMed ID: 9022281
[TBL] [Abstract][Full Text] [Related]
11. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity.
Sawyer TK; Sanfilippo PJ; Hruby VJ; Engel MH; Heward CB; Burnett JB; Hadley ME
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5754-8. PubMed ID: 6777774
[TBL] [Abstract][Full Text] [Related]
12. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
13. Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.
Murata J; Ayukawa K; Ogasawara M; Fujii H; Saiki I
Invasion Metastasis; 1997; 17(2):82-93. PubMed ID: 9561027
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeled alpha-melanocyte-stimulating hormone analogs for receptor-mediated targeting of melanoma: from tritium to indium.
Eberle AN; Froidevaux S
J Mol Recognit; 2003; 16(5):248-54. PubMed ID: 14523936
[TBL] [Abstract][Full Text] [Related]
15. [The effect of alpha-melanocyte-stimulating hormone and its analog on the growth of human melanoma cell lines with different phenotypes].
Morozova LF; D'iakov VL; Sukhanov VA
Tsitologiia; 1993; 35(1):101-4. PubMed ID: 8386407
[TBL] [Abstract][Full Text] [Related]
16. [111In]-DTPA-labeled analogues of alpha-melanocyte-stimulating hormone for melanoma targeting: receptor binding in vitro and in vivo.
Bagutti C; Stolz B; Albert R; Bruns C; Pless J; Eberle AN
Int J Cancer; 1994 Sep; 58(5):749-55. PubMed ID: 8077062
[TBL] [Abstract][Full Text] [Related]
17. Fluorine-18-labeled [Nle4,D-Phe7]-alpha-MSH, an alpha-melanocyte stimulating hormone analogue.
Vaidyanathan G; Zalutsky MR
Nucl Med Biol; 1997 Feb; 24(2):171-8. PubMed ID: 9089709
[TBL] [Abstract][Full Text] [Related]
18. The melanotropic peptide, [Nle4,D-Phe7] alpha-MSH, stimulates human melanoma tyrosinase activity and inhibits cell proliferation.
Jiang J; Sharma SD; Nakamura S; Lai JY; Fink JL; Hruby VJ; Hadley ME
Pigment Cell Res; 1995 Dec; 8(6):314-23. PubMed ID: 8789740
[TBL] [Abstract][Full Text] [Related]
19. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
20. Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells.
Siegrist W; Solca F; Stutz S; Giuffrè L; Carrel S; Girard J; Eberle AN
Cancer Res; 1989 Nov; 49(22):6352-8. PubMed ID: 2804981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
